Bayer opposes reviving Tevra's US antitrust claims over tick treatments
MLex Summary: Bayer Healthcare asked a US appeals court to affirm orders against Tevra Brands’ antitrust case over topical flea and tick treatments. “Tevra’s lawsuit was premised on several questionable assumptions,...To view the full article, register now.
Already a subscriber? Click here to view full article